In the Macquarie broker update they said 40% of sales and 30-35% of profit - given NUF is largely a distributor of glyphosate that seems to make sense, certainly not the same operating leverage as Monsanto. Monsanto had previously flagged a halving of glyphosate profit in 2012 but pulled this fwd to 2010 in the recent update.
If NUF miss earnings by 15% they will come in at $187m NPAT.....Macquarie have factored in $180m. So I think hitting $187m would be a positive for the SP.
I still the China takeover talk can't be discounted....the rumour was they recently had some due diligence done and surely this latest SP weakness presents a big opportunity.
what now?, page-30
Add NUF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.77 |
Change
0.010(0.27%) |
Mkt cap ! $1.443B | |||
| Open | High | Low | Value | Volume |
| $3.75 | $3.77 | $3.72 | $1.142M | 304.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6264 | $3.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.77 | 3495 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| NUF (ASX) Chart |